Drug Approval
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Drug Approval
May 2, 2024, 02:53 |
Drugs
FDA approves lutetium Lu 177 dotatate for pediatric patients 12 years and older with GEP-NETS
FDA Approves the First Radioactive Drug for Pediatric Neuroendocrine Tumors the U.S. Food and Drug…
Apr 24, 2024, 22:17 |
Drugs
Giselle Sholler: Exciting to see Norgine moving forward with seeking approval for DFMO internationally
Giselle Sholler, Division Chief, Pediatric Hematology and Oncology at Penn State Health Children’s Hospital, shared…
Apr 19, 2024, 15:52 |
Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 18, 2024, 13:52 |
Blog
Bishal Gyawali: Sometimes we harm the patients by lowering the bar simply because the disease is bad
Bishal Gyawali, Associate professor in medical oncology and public health sciences in the Division of…
Apr 3, 2024, 14:15 |
Insight
FDA Oncology medical reviewers wrote more than 500 articles for peer-reviewed journals from 2018-2023
FDA Oncology posted on X: "DYK? FDA Oncology medical reviewers wrote more than 500 articles for…
All:
5
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube